HOPE4MCI Privacy Policy
Welcome to www.HOPE4MCI.org (also referred to as “Site”) owned and operated by AgeneBio, Inc. (also referred to as “AgeneBio”, “us” or “we”). This Privacy Policy is designed to tell you about our practices regarding the collection, use, and disclosure of information that is collected through this Site. This Privacy Policy does not apply to information that you provide to us through other means or that AgeneBio collects through other websites that do not link to this Privacy Policy.
Please be sure to read this Privacy Policy before using or submitting information to this Site. This Privacy Policy is the sole authorized statement of AgeneBio’s practices concerning the collection, use and protection of personal information through this Site.
Information Collection & Use
Personal Information
We may collect your email address when you voluntarily provide it to us through the Site or by sending us an email. We may also collect any other personal information that you provide when you contact us.
We may use any personal information that we collect to provide this Site, for our clinical research purposes, and to operate our programs. Among other uses, we may use personal information to respond to your request for information about the trial, including providing you with updates about the trial.
Non-Personal Information
Eligibility screening tool. You may choose to use our screening tool to determine your eligibility for the trial. Through this screening tool, we may request certain health information from you. We may also ask for your ZIP code to inform you about study sites near you. This information is not combined with your personal information and we do not use this information to identify you. We use the information that you submit when using our eligibility screening feature only to determine your eligibility to participate in the trial. We do not retain this information when you leave the Site.
Other non-personal information. As you navigate through this Site, we may collect certain non-personal information using various technologies and means, such as cookies, Internet tags, web beacons and navigational data collection. For example, your Internet browser automatically transmits to this Site some of this non-personal information, such as the URL of the website you just came from, your Internet Protocol (IP) address, and the browser version your computer is currently using. Such information may also include the time and date of your visit and the pages you viewed on this Site. You may be able to set your browser to notify you when a cookie is sent or to refuse cookies altogether, but certain features of this Site might not work without cookies.
We may use non-personal information collected through this Site for a variety of purposes, such as to improve the content of the Site and otherwise maintain the Site; to customize the Site to your preferences; for statistical, research, and other analytical purposes; to monitor the Site for compliance with our Terms of Service and applicable law; for our marketing and research purposes; and for any other purpose specified at the point of collection.
We may also use service providers, such as Google Analytics, that may use cookies to collect information about your online activities across this and other sites over time for non-advertising purposes such as those described above. To learn more about how Google Analytics collects and processes data and the choices Google may offer to control these activities, you may visit http://www.google.com/intl/en/policies/privacy/partners/.
Disclosure of Information
We may share your personal information as follows:
- With the government and private partners that are administering the HOPE4MCI trial with AgeneBio;
- With agents, contractors, service providers, and partners that we use to support our business;
- With our affiliates for their own purposes including research;
- For our own research purposes;
- As part of a sale, merger, assignment, or other transfer of all or part of AgeneBio or any of its assets, affiliates, lines of business, or products, including at bankruptcy;
- To respond to law enforcement requests, subpoenas, or other legal process, or where we determine that disclosure is required by applicable laws, court orders, or government regulations;
- To enforce our Terms of Use; to investigate, respond to or resolve problems or inquiries; to protect, enforce, or defend our rights or property; or to permit us to pursue available remedies or limit the damages that we may sustain; or
- With your consent or as otherwise disclosed at the time of collection.
In addition, we may use and disclose to others non-personal information collected through this Site without any restrictions.
Links to Other Websites
This Site may contain links or references to other websites. Please be aware that we do not control these linked websites and that this Privacy Policy does not apply to those websites. We encourage you to read the privacy policy of any other website before you provide any information to that website’s owner.
Correction and Deletion of Personal Information
To keep personal information that you provide through this Site accurate, current and complete, please contact us as specified below to request that we update or correct such information in our possession.
If you request that we delete your personal information, please note that we may need to retain certain personal information for record-keeping purposes, and there may also be residual personal information that will remain within our databases and other records, which will not be removed. We are not responsible for removing personal information from the databases of third parties with whom we have already shared your personal information and shall not be responsible for any damages resulting from the loss, corruption or unauthorized acquisition or misuse of such personal information.
Your Choices and How to Contact Us
You can opt out of marketing emails from AgeneBio by following the unsubscribe link in any marketing email that we send to you or by emailing clinicaltrial@agenebio.com.
If you have questions, comments, or concerns about this Privacy Policy or the information practices of this Site, or if you would like to opt out of future marketing communications from AgeneBio, please contact us by sending a letter to:
AgeneBio, Inc.
1101 E. 33rd Street, Suite C310
Baltimore, MD 21218
443.451.7130
Attention: General Counsel
Privacy Policy Updates
Please note that we reserve the right to revise this Privacy Policy at any time at our sole discretion. Therefore, you are urged to review this Privacy Policy each time you access this Site to ensure that you are familiar with the most current version. Use of this Site following such modification constitutes your acceptance of the revised Privacy Policy then in effect.
Effective date of this Privacy Policy: November 11, 2015.
If you suspect that you or a loved one is experiencing unusual memory loss, please see your healthcare provider.
About the Study
The HOPE4MCI Alzheimer’s Trial is assessing the efficacy and safety of an investigational medication to determine if it can treat the symptoms associated with Mild Cognitive Impairment due to Alzheimer’s Disease (MCI due to AD) and control further progression leading to the onset of Alzheimer’s dementia.